The management of patients with thyroid ophthalmopathy is complex and challenging. The evidence base is weak for the long-term effectiveness of many currently used interventions. However there is general agreement that careful control of any associated thyroid dysfunction is mandatory. Moreover, many of the non-surgical therapies can have serious metabolic and haematological side effects. For these reasons we feel that the concept of a joint ophthalmology – endocrine clinic has much to commend it. It certainly works well in Norwich and is much appreciated by our patients.

Bijan Beigi, MD FRCS FRCOphth, Consultant Ophthalmic Surgeon
Richard Greenwood, FRCP, Consultant Endocrinologist

The authors would like to thank Mr Nick Astbury for his input.


© Bijan Beigi 2020 - www.ophthalmol.com - Tel: 0870 850 1093